. Age-dependent regulation of rat intestinal type IIb sodium-phosphate cotransporter by 1,25-(OH)2 vitamin D3. Am J Physiol Cell Physiol 282: C487-C493, 2002. First published October 24, 2001 10.1152/ajpcell.00412.2001The current studies were designed to characterize type IIb sodium-inorganic phosphate (Pi) cotransporter (NaPi-IIb) expression and to assess the effect of 1,25-(OH)2 vitamin D3 on NaP i-IIb gene expression during rat ontogeny. Sodium-dependent Pi absorption by intestinal brush-border membrane vesicles (BBMVs) decreased with age, and NaPi-IIb gene expression also decreased proportionally with age. 1,25-(OH)2 vitamin D3 treatment increased intestinal BBMV Pi absorption by ϳ2.5-fold in suckling rats and by ϳ2.1-fold in adult rats. 1,25-(OH)2 vitamin D3 treatment also increased NaPiIIb mRNA abundance by ϳ2-fold in 14-day-old rats but had no effect on mRNA expression in adults. Furthermore, in rat intestinal epithelial (RIE) cells, 1,25-(OH)2 vitamin D3 increased NaPi-IIb mRNA abundance, an effect that was abolished by actinomycin D. Additionally, human NaPi-IIb gene promoter activity in transiently transfected RIE cells showed ϳ1.6-fold increase after 1,25-(OH) 2 vitamin D3 treatment.
INORGANIC PHOSPHATE (P i ) plays important roles in growth, development, bone formation, acid-base regulation, and cellular metabolism. The rate of growth is limited by the availability of P i . A transport system capable of accumulating P i against the electrochemical gradient is vital for normal development. The sodiumphosphate (NaP i ) cotransporters are plasma membrane-bound symporters that mediate the movement of extracellular P i ions into cells coupled with sodium ions. Three families of NaP i cotransporters have been identified from mammalian cells in recent years, called types I, II, and III (35, 53, 54) . These proteins play important roles in regulating phosphate absorption across cell membranes and in maintaining serum P i levels.
The small intestine is an important site for phosphate absorption. Early studies showed that P i transport through the apical membrane of small intestinal epithelial cells is coupled with sodium (4, 7, 12, 21, 29, 43, 47, 48) . One transporter involved in intestinal P i absorption is the type IIb sodium-coupled P i cotransporter (NaP i -IIb), which has been cloned from rodents and humans (20, 25, 28, 55) . P i absorption is modulated by many physiological factors, including hormonal and dietary factors (2) . Glucocorticoids inhibit intestinal sodium-dependent P i (Na/P i ) absorption (5, 38) . EGF decreases intestinal Na/P i absorption at least partially by inhibiting NaP i -IIb mRNA expression (56) . Estrogen also plays a possible role in regulating intestinal P i absorption (41) . Phosphate content of the diet also regulates intestinal P i absorption, and P i deprivation stimulates intestinal Na/P i absorption (10, 37, 42, 44, 49) .
Vitamin D 3 , a steroid hormone, plays a central role in modulating phosphate homeostasis and P i uptake by the small intestine (1, 19) . The active form of vitamin D 3 is 1,25-(OH) 2 vitamin D 3 , which is mainly synthesized in kidney from 25-(OH) vitamin D 3 . 1,25-(OH) 2 vitamin D 3 binds the vitamin D receptor (VDR) to elicit its effect on regulation of gene expression. 1,25-(OH) 2 vitamin D 3 plays important roles in calcium and phosphate homeostasis, regulation of the parathyroid hormone system, inhibition of cell growth, and induction of cellular differentiation (9) . Many previous studies showed that 1,25-(OH) 2 vitamin D 3 increases intestinal P i absorption through modulation of Na/P i absorption (13, 16, 17, 22, 23, 27, 30, 33, 34, 39, 40, 52) . In adult rodents, this increase is at least partially mediated by modulation of NaP i -IIb protein expression (26) . However, there is a lack of evidence demonstrating direct regulation of NaP i -IIb gene expression by 1,25-(OH) 2 vitamin D 3 .
As reported in the current communication, we initially detected ontogenic changes in NaP i -IIb gene expression in rats and a significant increase in NaP i -IIb mRNA abundance and brush-border membrane Na/P i uptake in 1,25-(OH) 2 
MATERIALS AND METHODS
Animals. Sprague-Dawley rats at 2, 3, and 6 wk and 95-100 days of age were used for these studies. Two-weekold and adult (90-100 days) rats were used for 1,25-(OH) 2 vitamin D3 studies. Animals received subcutaneous injections of 1,25-(OH) 2 vitamin D3 (6 g/kg body wt, 1 dose; Sigma, St. Louis, MO) or vehicle [ethanol-propylene glycol (1:4, vol/vol)]. Sixteen hours after the injection, rats were killed and jejunal mucosa was harvested and used for mRNA and brush-border membrane vesicle (BBMV) purification. All animal work was approved by the University of Arizona Institutional Animal Care and Use Committee.
Cell culture. RIE cells were a gift from Dr. Raymond DuBois (Dept. of Medicine; Vanderbilt University, Nashville, TN). RIE cells are nontransformed, epithelium-derived cells isolated from the small intestinal epithelium of a 20-day-old rat (3). They were cultured as previously described (57) . Media and other reagents used for cell culture were purchased from Irvine Scientific (Irvine, CA). In 1,25-(OH) 2 vitamin D3 treatment experiments, cells were incubated with 100 nM 1,25-(OH) 2 vitamin D3 for 16 h before cells were harvested. For transcriptional assays, cells were pretreated with actinomycin D (100 nM; Calbiochem-Novabiochem; San Diego, CA) for 2 h and then treated with 100 nM 1,25-(OH) 2 vitamin D3 for 16 h in the presence of actinomycin D before cells were harvested.
RNA purification and Northern blot analyses. mRNA was isolated from RIE cells and rat jejunal mucosa with the Fast-Track mRNA purification kit (Invitrogen; Carlsbad, CA). Ten micrograms of mRNA was used for Northern blot analyses with rat NaP i-IIb cDNA probes (56) under highstringency washing conditions (several washes with a 0.1ϫ sodium chloride-sodium citrate-0.1% SDS solution at 65°C) as described previously (11) . 1B15 (encoding rat cyclophilin; Ref. 15) cDNA-specific probes were used as internal standards for quantitating NaP i-IIb gene expression. Blots were exposed to a phosphorimaging screen, and band intensities were determined with Quantity One software (FX Molecular Imager; Bio-Rad, Hercules, CA). NaP i-IIb gene expression levels were estimated by taking the ratio of hybridization intensities of NaP i-IIb mRNA over 1B15 mRNA. The experiment was repeated three times with mRNA isolation from different groups of animals.
Na/P i uptake analysis in BBMVs. BBMVs were prepared from rat jejunal mucosa, and Na/P i uptake was carried out as previously described (4, 24, 36) . The contribution of Na/P i uptake was calculated by subtracting the sodium-independent uptake values observed in the absence of sodium from the uptake values in the presence of sodium. The experiment was repeated three times with BBMV isolated from different groups of animals. PCR analysis to detect NaP i-IIb expression in RIE cells. mRNA was purified from RIE cells cultured in normal medium. RT-PCR conditions were identical to those described in a previous publication (56) . The primers used to detect NaP iIIb were designed from rat NaP i-IIb cDNA (GenBank accession no. AF157026). The forward primer was at 1446-1465 bp (5Ј-AGCCCAGGCAACACATTGA-3Ј), and the reverse primer was at 1899-1917 bp (5Ј-ACACCATGCAGCAGA-CACG-3Ј). The expected amplification size from NaP i-IIb mRNA is 472 bp. The primers used to detect ␤-actin were purchased from Stratagene (La Jolla, CA). The size of the amplified product from the ␤-actin gene is 661 bp.
Semiquantitative RT-PCR analysis of NaP i-IIb gene expression. mRNA was purified from RIE cells treated for 16 h with vehicle (ethanol) or 1,25-(OH) 2 vitamin D3 (100 nM). RT-PCR conditions were described previously (56) . Subsaturation levels of cDNA templates needed to produce a dosedependent amount of PCR product were defined in initial experiments by testing a range of template concentrations. Subsequent PCR was carried out with subsaturation levels of RT reactions with identical amplification parameters. PCR was performed with rat NaP i-IIb or ␤-actin primers in separate reactions; equal volumes of both PCR reactions were loaded on the same gel and visualized with ethidium bromide, and the optical density of each band was determined by gel-doc analysis. NaP i-IIb mRNA expression levels were estimated by taking a ratio of NaP i-IIb over ␤-actin amplicon optical densities.
Construction of reporter plasmids. Reporter plasmids used in this study were derived from pGL3-Basic (Promega), which contains the firefly luciferase reporter gene. The human NaP i-IIb promoter-reporter constructs pGL3/Ϫ2783 bp, pGL3/Ϫ1103 bp, and pGL3/Ϫ181 bp were made by restriction enzyme digestion and PCR (56) . The 3Ј-end of all constructs ends at ϩ15 bp of the human NaP i-IIb gene. All constructs were confirmed by sequencing on both strands.
Transient transfection and functional promoter analysis. RIE cells were cultured in 24-well plates. When cells reached 70-80% confluence, liposome-mediated transfection was performed as follows. Promoter vector DNA (0.5 g), pRL-CMV (30 ng, Renilla luciferase reporter construct used as an internal standard; Promega), and Lipofectamine (5 l; GIBCO BRL, Grand Island, NY) were mixed with 200 l of Opti-MEM medium (GIBCO BRL) for 30 min at room temperature. The mixture was then added to the cells, and they were incubated for 5 h, followed by the addition of an equal volume of Dulbecco's modified Eagle's medium (DMEM) containing 20% fetal bovine serum (FBS). The next day, the medium was removed and replaced with standard medium with 10% FBS. Twenty-four hours later, cells were harvested for reporter gene assays. For 1,25-(OH) 2 vitamin D3 treatment, 100 nM 1,25-(OH) 2 vitamin D3 or vehicle (ethanol) was added for 16 h before cells were harvested. Promoter reporter assays were performed using the Dual Luciferase assay kit according to the manufacturer's instructions (Promega). Luciferase activities were measured with a luminometer (Femtomaster FB 12; Berthold Detection System, Pforzheim, Germany), and all assays provided data that were well within the linear range of the instrument.
Statistical analysis. ANOVA post hoc tests (StatView 5.0.1 version; SAS Institute, Cary, NC) were used to compare values of the experimental data. P values of Ͻ0.05 were considered significant.
RESULTS

Effect of age on NaP i -IIb gene expression in rat jejunum.
Jejunal mRNAs from 2-wk, 3-wk, 6-wk, and adult rats were purified, and Northern blot analyses were performed with NaP i -IIb-and 1B15-specific cDNA probes (Fig. 1 ). Expression levels of NaP i -IIb mRNA were significantly different among age groups, with highest expression seen in 2-wk-old rats and expression levels gradually decreasing three-to fourfold into adulthood.
Effect of 1,25-(OH) 2 vitamin D 3 treatment on BBMV phosphate absorption in rat jejunum. Two-week-old and adult rats were treated with 1,25-(OH) 2 vitamin D 3 , BBMVs were purified from jejunum, and Na/P i absorption was measured by a membrane filtration method. Na/P i uptake (in nmol P i ⅐ mg protein Ϫ1 ⅐ 10 s Ϫ1 ) in suckling rats was significantly higher than in adult rats (94.6 Ϯ 4.7 in 2-wk-old rats vs. 30.4 Ϯ 2.3 in adult rats; Fig. 2A ). Vitamin D 3 treatment increased Na/P i absorption in both suckling and adult rats (94. Fig. 2A ), with the fold inductions being similar (Fig. 2B) .
Effect of 1,25-(OH) 2 vitamin D 3 treatment on NaP iIIb mRNA levels in rat jejunum. Two-week-old and adult rats were treated with 1,25-(OH) 2 vitamin D 3 , mRNA was purified from jejunal mucosa, and Northern blots were performed with rat NaP i -IIb and 1B15 cDNA probes. Hybridization patterns clearly showed that intestinal NaP i -IIb mRNA abundance significantly increased approximately twofold in 1,25-(OH) 2 vitamin D 3 -treated 2-wk-old-rats, but no change was detected in adult rats (Fig. 3) Fig. 1 . Expression of the intestinal type IIb sodium-phosphate (Pi) cotransporter (NaPi-IIb) gene in different-aged rats: 2 (2w), 3 (3w), and 6 (6w) weeks and adult (Ad). A: 10 g of mRNA isolated from rat jejunal mucosa was hybridized with rat NaPi-IIb cDNA and 1B15 probes. Blots were processed under high-stringency conditions. NaPi-IIb probes recognized a hybridization signal at ϳ4.4 kb, and 1B15 probes recognized a hybridization signal at ϳ1.0 kb. Two of three experiments are shown. B: phosphorimage analysis of rat NaPi-IIb mRNA expression at different ages. Results are means Ϯ SE from 3 separate experiments. Values with different superscript letters are significantly different at P Ͻ 0.044. (Fig. 5) . In these experiments, actinomycin D did not alter basal expression levels of either the NaP i -IIb or ␤-actin genes in RIE cells.
Human NaP i -IIb gene promoter analysis in RIE cells. To determine whether the 5Ј-flanking region of the human NaP i -IIb gene contains a functional promoter in RIE cells, three constructs (pGL3/Ϫ2783 bp, pGL3/ Ϫ1103 bp, and pGL3/Ϫ181 bp) were transfected by Lipofectamine into RIE cells (57) . Promoter reporter gene assays were performed 48 h after transfection. The promoter assay data showed that all promoter constructs were functional in RIE cells (Fig. 6A) .
To test the effect of 1,25-(OH) 2 vitamin D 3 on human NaP i -IIb gene promoter activity, RIE cells were first transfected with promoter constructs and then treated with 100 nM 1,25-(OH) 2 vitamin D 3 or vehicle for 16 h before cells were harvested. 1,25-(OH) 2 vitamin D 3 treatment of transfected RIE cells did not affect the activity of the internal control construct, Renilla luciferase driven by the CMV promoter. The data showed that human NaP i -IIb promoter activity increased ϳ1.6-fold with the pGL3/Ϫ2783 bp and pGL3/Ϫ1103 bp constructs in 1,25-(OH) 2 vitamin D 3 -treated RIE cells compared with control cells (Fig. 6B) . The pGL3/Ϫ181 bp construct showed no effect with 1,25-(OH) 2 vitamin D 3 treatment.
DISCUSSION
Earlier studies indicated that intestinal Na/P i absorption declined with age in several mammalian species (4, 6, 45) . These observations suggested that the expression of the transport protein(s), which is responsible for Na/P i absorption, likely decreases with age. Our data demonstrate that NaP i -IIb gene expression decreases with age, and this observation correlates well with the functional studies. Thus it seems likely that NaP i -IIb expression contributes to the ontogenic changes seen in intestinal P i absorption.
Studies also showed that 1,25-(OH) 2 vitamin D 3 treatment stimulates intestinal Na/P i absorption (13, 14, 16, 17, 22, 23, 27, 30, 33, 34, 39, 40, 52 ). More 3 . Effect of 1,25-(OH)2 vitamin D3 on rat intestinal NaPi-IIb mRNA expression. A: 10 g of mRNA isolated from rat jejunal mucosa was hybridized with rat NaPi-IIb cDNA and 1B15 cDNA probes. Blots were processed under high-stringency conditions. NaPi-IIb probes recognize a hybridization signal at ϳ4.4 kb, and 1B15 probes recognize a hybridization signal at ϳ1.0 kb. Two of three experiments are shown. B: phosphorimage analysis of rat intestinal NaPi-IIb mRNA abundance in 1,25-(OH)2 vitamin D3-treated (6 g/kg body wt once; killed 16 h later) or nontreated rats at 2 wk and adult ages. Results are means Ϯ SE from 3 separate experiments. *P Ͻ 0.01 for vehicle treatment vs. 1,25-(OH)2 vitamin D3 treatment in 2-wk-old rats.
recently, two groups showed that the stimulation of intestinal P i absorption by 1,25-(OH) 2 vitamin D 3 in adult rodents is not mediated by increases in NaP i -IIb gene expression (26, 32) . Our results showed that 1,25-(OH) 2 vitamin D 3 treatment increased intestinal Na/P i uptake in adult rats but not NaP i -IIb mRNA expression, which is comparable to these studies. The increase in P i uptake is most likely the result of increased apical NaP i -IIb protein expression in adult animals (26) . Our data also showed that 1,25-(OH) 2 vitamin D 3 treatment increased intestinal Na/P i absorption and NaP i -IIb mRNA expression in suckling rats, which suggests that the effect of 1,25-(OH) 2 vitamin D 3 on NaP i -IIb gene expression is age specific.
To decipher the molecular mechanism of 1,25-(OH) 2 vitamin D 3 regulation of intestinal NaP i -IIb gene expression in suckling animals, we explored the RIE cell line as an in vitro model. Our results demonstrate that the NaP i -IIb gene is endogenously expressed in RIE cells and that it is 1,25-(OH) 2 vitamin D 3 responsive. Furthermore, we performed Na-P i cotransport studies in RIE cells with 1,25-(OH) 2 vitamin D 3 treatment and found that activity was increased by ϳ25% and was blockable by actinomycin D treatment (data not shown). However, these data are difficult to interpret because RIE cells likely contain other endogenous Na-P i cotransporters, including ubiquitously expressed type III Na-P i cotransporters and possibly other unidentified Na-P i cotransporters. It is further possible that this other Na-P i cotransporter(s) may also be regulated by 1,25-(OH) 2 vitamin D 3 (as has been shown for the type III Na-P i cotransporters; Ref. 32) , and thus it is extremely difficult to assess the single contribution of NaP i -IIb cotransporters. Moreover, we could not selectively study the activity of NaP i -IIb in RIE cells, because no specific inhibitors are available at this time. Our intention was simply to demonstrate that RIE cells are a good in vitro model to study NaP i -IIb gene regulation by 1,25-(OH) 2 vitamin D 3 , as exemplified by the facts that the cells endogenously express this gene and that the gene is 1,25-(OH) 2 vitamin D 3 responsive. However, these data suggest that other in vitro models would have to be developed to study posttranscriptional regulation of the NaP i -IIb gene.
In vivo studies in suckling rats and in vitro studies in RIE cells showed that 1,25-(OH) 2 vitamin D 3 treat- Transfection of cells with three NaP i -IIb gene promoter constructs (pGL3/Ϫ2783 bp, pGL3/Ϫ1103 bp, and pGL3/Ϫ181 bp) resulted in significant reporter gene expression. This finding suggests that the basal promoter region of the NaP i -IIb gene is located within the Ϫ181 bp region in RIE cells, as was previously described in Caco-2 cells (57) . Interestingly, the promoter construct pGL3/Ϫ2783 bp showed lower activity in transfected RIE cells compared with Caco-2 cells (56) . Furthermore, the two longer promoter constructs (pGL3/Ϫ2783 bp and pGL3/Ϫ1103 bp) were responsive to 1,25-(OH) 2 vitamin D 3 treatment, but the smaller construct (pGL3/Ϫ181 bp) was unresponsive. This observation suggests that the putative 1,25-(OH) 2 vitamin D 3 response element(s) is located between 181 and 1103 bp upstream of the transcriptional initiation site.
Vitamin D 3 responsive elements (VDRE) have been identified from many genes, including the human renal NaP i -IIa (NaPi-3) gene (50), the rat osteocalcin (OSC) gene, the mouse osteopontin (MOP) gene, the rat calbindin D-9k (CaBP) gene, and the human parathyroid hormone (PTH) gene (18, 46) . We searched the human NaP i -IIb gene promoter region from Ϫ181 bp to Ϫ1103 bp for putative VDREs, but no classical VDR binding sequences were identified. This may therefore classify the human NaP i -IIb gene in a group of genes that are responsive to 1,25-(OH) 2 vitamin D 3 treatment but do not have classic VDRE sequences in their promoter regions (8, 46, 51) . These data may also suggest that there is a novel VDRE present in this gene, or alternatively, the 1,25-(OH) 2 vitamin D 3 response could be mediated by a trans-acting factor that acts independently of the VDR.
In summary, we showed that the decrease in Na/P i absorption during development correlates with decreased NaP i -IIb gene expression in the intestinal mucosa. We also demonstrated that 1,25-(OH) 2 vitamin D 3 treatment increases NaP i -IIb mRNA abundance in suckling rats and RIE cells and NaP i -IIb gene promoter activity in transfected RIE cells. Because actinomycin D treatment blocked 1,25-(OH) 2 vitamin D 3 -induced increases in NaP i -IIb mRNA expression in RIE cells, we hypothesize that a transcriptional mechanism is likely involved. Further studies will focus on identification of the responsive region in the promoter and the trans-acting factors involved in regulation of the NaP i -IIb gene by 1,25-(OH) 2 vitamin D 3 .
